Novo Nordisk Sharpens Its Outlook But Warns Risks Remain Later In 2017

 
• By Sten Stovall
  
Market outlook
Novo Nordisk Narrowed Its 2017 Guidance
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip